Roshawn A. Blunt
CIK 1787773 · last filed 2025-06-20
Roshawn A. Blunt is a corporate insider who has filed 8 SEC Form 4 insider transactions across 3 companies since 2020. The most recent filing, for KRON, was dated Jun 20, 2025.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
8
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Kronos Bio, Inc. (KRON) Delisted | Director | — | $0.88 | — | $0 | 5 | 2025-06-20 |
| OnKure Therapeutics, Inc. (RPHM) Delisted | Director | — | $18.20 | — | $0 | 2 | 2023-06-08 |
| DMK PHARMACEUTICALS Corp (ADMP) Delisted | Director | — | $0.78 | — | $0 | 1 | 2020-02-13 |
Recent Filings
8 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-20 | Kronos Bio, Inc. (KRON) Delisted | Disp (D) | — | $0 | EDGAR |
| 2024-06-26 | Kronos Bio, Inc. (KRON) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-26 | Kronos Bio, Inc. (KRON) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-08 | OnKure Therapeutics, Inc. (RPHM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-08-02 | OnKure Therapeutics, Inc. (RPHM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-29 | Kronos Bio, Inc. (KRON) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-11-15 | Kronos Bio, Inc. (KRON) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-02-13 | DMK PHARMACEUTICALS Corp (ADMP) Delisted | Grant (A) | — | $0 | EDGAR |